Outcome analysis of pediatric hemophagocytic lymphohistiocytosis

被引:20
|
作者
Chen, Tsung-Yen [1 ,2 ]
Hsu, Mei-Hsin [1 ,3 ]
Kuo, Hsuan-Chang [1 ,4 ,5 ]
Sheen, Jiunn-Ming [6 ]
Cheng, Ming-Chou [1 ]
Lin, Ying-Jui [1 ,4 ]
机构
[1] Chang Gung Univ, Coll Med, Div Crit Care, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, 123 Tapei Rd, Kaohsiung 333, Taiwan
[2] I Shou Univ, Dept Pediat, E Da Hosp, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Div Neurol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[4] Chang Gung Univ, Coll Med, Div Cardiol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[5] Meiho Univ, Dept Nursing, Neipu Township, Taiwan
[6] Chang Gung Univ, Coll Med, Div Hematol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
关键词
Pediatric hemophagocytic syndrome; Hemophagocytic lympho histiocytosis; Macrophage activation syndrome; Mortality; Intensive care unit;
D O I
10.1016/j.jfma.2020.03.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease associated with rapid clinical deterioration and the need for intensive care; therefore, it is essential to identify clinical parameters related to mortality and establish prognostic factors correlated with unfavorable outcome in high risk patients whose treatment may fail. Methods: Between January 2004 and December 2018, a total of 51 pediatric patients (less than 18 years old) who fulfilled the diagnostic criteria of HLH-2004 with documented results of bone marrow investigations at Kaohsiung Chang Gung Memorial Hospital were enrolled. The treatment protocol was based on hemophagocytic lymphohistiocytosis-94 (HLH-94) and HLH-2004. We retrospectively reviewed electronic medical records (EMR) including clinical features, length of intensive care unit (ICU) stay, serological tests, microscopic reports of bone marrow examination, and ultrasound examination reports at diagnosis to identify prognostic factors. The patients were divided into four groups based on etiology; these included infection associated hemophagocytic syndrome (IAHS), macrophage activation syndrome (MAS), malignancy associated hemophagocytic lymphohistiocytosis (MA-HLH), and idiopathic hemophagocytic lymphohistiocytosis (IHLH) to identify differences among the groups. Results: Out of 51 patients enrolled, 27 patients had IAHS, 12 MAS, 8 MA-HLH, and 4 IHLH. The median age at diagnosis was 7 years. The overall mortality rate was 15.7% (there was no mortality in the MA-HLH group); the mean length of ICU stay was 6 +/- 20.8 days. Longer activated partial thromboplastin time (aPTT) (p = 0.007), lower sodium concentration (p = 0.0007), and higher creatinine (p = 0.032) and aspartate aminotransferase (AST) (p = 0.017) were significantly related to mortality. Multivariate Cox regression analysis demonstrated that aPTT (p = 0.045, HR = 1.03, 95% CI = 1.0-1.1) was an independent risk factor for mortality. The receiver operating characteristic (ROC) curve showed that aPTT longer than 44.35 s was the cutoff value predicting mortality, with a sensitivity and specificity of 72% and 66.7%, respectively. Conclusion: MA-HLH had the lowest mortality rate, as most children died from the underlying malignant disease and not from HLH. Impaired liver and renal functions were related to mortality. Prolonged aPTT > 44.35 s is a strong predictive factor for mortality. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 50 条
  • [21] Treatment of hemophagocytic lymphohistiocytosis
    Wang, Yini
    Wang, Zhao
    CURRENT OPINION IN HEMATOLOGY, 2017, 24 (01) : 54 - 58
  • [22] Screening of hemophagocytic lymphohistiocytosis in children with severe sepsis in pediatric intensive care
    El-Sayed, Zeinab A.
    El-Owaidy, Rasha H.
    Khamis, Mohammed A.
    Rezk, Ahmed R.
    SCIENCE PROGRESS, 2021, 104 (03)
  • [23] Nationwide analysis of adult hospitalizations with hemophagocytic lymphohistiocytosis and systemic lupus erythematosus
    Noboa, Maria Emilia Romero
    Lopez-Arevalo, Hugo
    Patel, Axi R.
    Arora, Shilpa
    Manadan, Augustine M.
    CLINICAL RHEUMATOLOGY, 2023, 42 (08) : 2091 - 2095
  • [24] Approaching hemophagocytic lymphohistiocytosis
    Chinnici, Aurora
    Beneforti, Linda
    Pegoraro, Francesco
    Trambusti, Irene
    Tondo, Annalisa
    Favre, Claudio
    Coniglio, Maria Luisa
    Sieni, Elena
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] Hemophagocytic Lymphohistiocytosis in the Elderly
    Altook, Reyna
    Ruzieh, Mohammed
    Singh, Avneet
    Alamoudi, Wael
    Moussa, Zeinab
    Alim, Hussam
    Safi, Fadi
    Duggan, Joan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 357 (01) : 67 - 74
  • [26] Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: Diagnostic Challenges and Determinants of Outcome
    Kurver, Lisa
    Seers, Timothy
    van Dorp, Suzanne
    van Crevel, Reinout
    Pollara, Gabriele
    van Laarhoven, Arjan
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (04):
  • [27] Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU
    Gregory, Jillian
    Greenberg, Jay
    Basu, Sonali
    PEDIATRIC CRITICAL CARE MEDICINE, 2019, 20 (04) : E185 - E190
  • [28] Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
    Eloseily, Esraa M.
    Weiser, Peter
    Crayne, Courtney B.
    Haines, Hilary
    Mannion, Melissa L.
    Stoll, Matthew L.
    Beukelman, Timothy
    Atkinson, T. Prescott
    Cron, Randy Q.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (02) : 326 - 334
  • [29] Hemophagocytic Lymphohistiocytosis Clinical Analysis of 103 Adult Patients
    Li, Jing
    Wang, Qian
    Zheng, Wenjie
    Ma, Jie
    Zhang, Wei
    Wang, Wenze
    Tian, Xinping
    MEDICINE, 2014, 93 (02) : 100 - 105
  • [30] Biomarkers in Pediatric Hemophagocytic Lymphohistiocytosis With Central Nervous System Involvement: A Cohort Study
    Zhao, Yunze
    Ou, Wenxin
    Wei, Ang
    Ma, Honghao
    Zhang, Liping
    Lian, Hongyun
    Zhang, Qing
    Wang, Dong
    Li, Zhigang
    Zhang, Rui
    Wang, Tianyou
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2024, 46 (07) : 364 - 372